Balyasny Asset Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-221,391
| Closed | -$3.5M | – | 2229 |
|
|
2024
Q4 | $3.5M | Sell |
221,391
-104,043
| -32% | -$1.65M | 0.01% | 945 |
|
|
2024
Q3 | $18.9M | Buy |
325,434
+236,798
| +267% | +$13.8M | 0.03% | 471 |
|
|
2024
Q2 | $4.05M | Buy |
88,636
+63,124
| +247% | +$2.88M | 0.01% | 880 |
|
|
2024
Q1 | $1.69M | Buy |
25,512
+7,797
| +44% | +$516K | ﹤0.01% | 1120 |
|
|
2023
Q4 | $704K | Sell |
17,715
-27,274
| -61% | -$1.08M | ﹤0.01% | 1313 |
|
|
2023
Q3 | $1.43M | Buy |
44,989
+34,666
| +336% | +$1.11M | ﹤0.01% | 1075 |
|
|
2023
Q2 | $415K | Buy |
+10,323
| New | +$415K | ﹤0.01% | 1519 |
|